https://the483.com/regeneron-otarmeni-hearing-loss/ The 483 en 2026-04-23T22:19:23.000Z FDA Clears Regeneron's Otarmeni, First Gene Therapy for Inherited Hearing Loss https://the483.com/abbvie-14b-durham-campus/ The 483 en 2026-04-23T17:35:37.000Z AbbVie Builds $1.4B Durham Campus, First in North Carolina https://the483.com/new-life-pharma-glp1-inspection-warning/ The 483 en 2026-04-23T16:39:00.000Z FDA Warns New Life Pharma After GLP-1 Inspection Refusal https://the483.com/sqm-sec-fcpa-probe-resumed/ The 483 en 2026-04-23T15:40:00.000Z Fined $30.5M in 2017, SQM Now Faces Resumed SEC FCPA Probe https://the483.com/merck-google-1b-ai-deal/ The 483 en 2026-04-23T14:51:34.000Z Cut $1B Google Cloud Deal, Merck Targets HCP Engagement https://the483.com/ionis-zilganersen-alexander-disease-fda/ The 483 en 2026-04-23T12:29:03.000Z Ionis Filed Zilganersen for Sept. 22 FDA Decision; First AxD Drug https://the483.com/amneal-kashiv-1b-biosimilar-buyout/ The 483 en 2026-04-23T03:11:09.000Z Buys Kashiv for $1.1B, Amneal Eyes $200B Biosimilar Market https://the483.com/forager-repay-1b-takeover/ The 483 en 2026-04-23T01:38:59.000Z Forager Bids $1B for Repay at 75% Premium https://the483.com/lilly-kelonia-7b-gene-delivery/ The 483 en 2026-04-23T00:51:19.000Z Paid $7B for Kelonia, Lilly Bets on In Vivo Gene Delivery https://the483.com/smartmatic-fcpa-indictment-dismissal/ The 483 en 2026-04-22T22:19:55.000Z Smartmatic Fights First Corporate FCPA Indictment Since 2010 https://the483.com/pancreatic-cancer-herceptin-1998-turning-point/ The 483 en 2026-04-22T18:29:27.000Z Compared to Herceptin's 1998 Approval: Pancreatic Cancer Hits a Turning Point https://the483.com/novartis-abelacimab-cuts-cancer-trials/ The 483 en 2026-04-22T17:25:29.000Z Cut 2 Abelacimab Cancer Trials, Novartis Bets $925M on Afib https://the483.com/apollo-mckesson-mms-minority-stake/ The 483 en 2026-04-22T16:28:50.000Z Paid $1.25B, Apollo Takes 13% of McKesson's Surgical Unit https://the483.com/kyverna-miv-cel-sps-car-t-fda/ The 483 en 2026-04-22T15:33:19.000Z Kyverna Sweeps All KYSA-8 Endpoints: 46% SPS Improvement, FDA Filing Next https://the483.com/gilead-arcus-domvanalimab-tigit-exit/ The 483 en 2026-04-22T14:38:41.000Z Gilead Cuts Arcus TIGIT Option After Domvanalimab's 2 Trial Failures https://the483.com/lilly-kelonia-7b-gene-therapy/ The 483 en 2026-04-22T13:54:45.738Z Lilly Paid $7B for Kelonia's Gene Therapy Delivery Platform https://the483.com/utah-clinical-ai-sandbox/ The 483 en 2026-04-22T13:37:35.000Z Utah Built the Clinical AI Sandbox Founders Are Racing Toward https://the483.com/esma-mica-eu-crypto-exit/ The 483 en 2026-04-22T12:29:18.000Z ESMA Orders Unlicensed Crypto Firms Out of EU Markets by July 1 https://the483.com/merck-keytruda-triplet-fails-rcc/ The 483 en 2026-04-22T03:10:49.000Z Paid $5.76B: Merck's Keytruda Triplet Fails Both RCC Endpoints https://the483.com/adobe-cx-enterprise-outcome-pricing/ The 483 en 2026-04-22T02:56:00.000Z Adobe Ditches Token Pricing for AI, Charges by Outcome Now https://the483.com/chrome-gemini-ai-3b-users-agentic/ The 483 en 2026-04-22T02:54:00.000Z Google Wires Gemini AI Into Chrome's 3 Billion Users Overnight https://the483.com/lloyds-sameer-gupta-ai-chief-dbs/ The 483 en 2026-04-22T02:52:00.000Z Lloyds Picks DBS's Sameer Gupta as First Chief AI Officer, June Start https://the483.com/unitedhealth-15b-ai-2x-return/ The 483 en 2026-04-22T02:50:00.000Z UnitedHealth Pours $1.5B Into AI, Expects $3B Back in 18 Months https://the483.com/utah-doctronic-ai-prescription-refills/ The 483 en 2026-04-22T02:44:47.407Z Utah Cleared Doctronic for AI Prescription Refills. Who's Next? https://the483.com/coinbase-gemini-new-york-gambling-suit/ The 483 en 2026-04-22T02:42:44.074Z Sued Over Prediction Markets, Coinbase and Gemini Push Back https://the483.com/pace-act-occ-nonbank-fintechs/ The 483 en 2026-04-22T02:40:43.398Z PACE Act Cuts 40-State License Requirement for Payment Fintechs https://the483.com/roche-fenebrutinib-death-imbalance-phase3/ The 483 en 2026-04-22T02:40:01.321Z Cleared Phase 3 Twice, Roche's Fenebrutinib Carries an 8-to-1 Death Imbalance https://the483.com/replimune-cuts-224-fda-rp1/ The 483 en 2026-04-22T02:39:42.272Z Replimune cuts 224 jobs after FDA's second RP1 rejection https://the483.com/nc-biotech-cell-gene-symposium-unc/ The 483 en 2026-04-22T02:10:00.000Z NC Biotech Gathers CAR-T Crowd at UNC Friday After $7B Kelonia Deal https://the483.com/roche-ms-pill-aubagio-liver/ The 483 en 2026-04-22T02:02:19.359Z Doubles Relapse-Free Interval: Roche's MS Pill Beats Aubagio, Flags Liver Risk https://the483.com/jetblue-congress-ai-surveillance-pricing/ The 483 en 2026-04-22T01:53:50.765Z Questioned by 2 Lawmakers, JetBlue Faces AI Pricing Probe https://the483.com/carvykti-smoldering-myeloma-dana-farber/ The 483 en 2026-04-22T01:39:09.000Z Carvykti shows promise in all 20 smoldering myeloma patients https://the483.com/merck-welireg-fails-first-line-kidney/ The 483 en 2026-04-22T00:42:37.000Z Failed: Merck's Welireg Combo in First-Line Kidney Cancer https://the483.com/amazon-price-fixing-california-ag/ The 483 en 2026-04-21T23:17:08.000Z Sued for Price-Fixing, Amazon Faces California AG at July 23 Hearing